Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
4.925
+1.075 (27.92%)
Oct 19, 2026, 9:30 AM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $668.54 million as of October 19, 2026. It is the 14,282nd most valuable company in the world and the 2,697th biggest in the United States. Its market cap has increased by 117.75% in one year.
Market Cap
668.54M
Enterprise Value
596.60M
Revenue
615.00K
Global Rank
Country Rank
#2,697 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has increased from 538.37M to 668.54M, an increase of 24.18%. That is a compound annual growth rate of 3.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 668.54M | 132.79% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 335.42M |
| Northwest Biotherapeutics | 266.93M |
| Glorywin Entertainment Group | 234.77M |
| Vaxart | 110.10M |
| BetterLife Pharma | 98.39M |
| ProText Mobility | 69.45M |
| NDT Pharmaceuticals | 63.05M |
| Nuo Therapeutics | 62.96M |